 | Andre Lapierre | Scientist |
| alapierre@goodmans.ca | vCard |
|
Bay Adelaide Centre - West Tower 333 Bay Street, Suite 3400 Toronto, ON M5H 2S7 |
Tel: 416.849.6020 Fax: 416.979.1234 |
Andre Lapierre (Ph.D., chemistry) is a Scientist at Goodmans. He collaborates with his colleagues in the Litigation Group in the pharmaceutical area, using his technical background to advance clients’ cases. Recent cases where successful outcomes for the client were achieved include:
- Janssen v. Apotex, 2021 FC 7 - successful challenge to the validity of a patent relating to a prostate cancer medication (abiraterone), on the bases of obviousness
- Eli Lilly v. Apotex, 2020 FC 814 – successful challenge to the validity and infringement of a patent relating to the process to make the active ingredient in an ED medication (tadalafil), on the bases of anticipation and obviousness
- Takeda Canada v. Apotex, 2015 FC 570 - successful challenge to the validity of a patent relating to a allergic rhinitis medication (ciclesonide), on the bases of obviousness
- Alcon Canada v. Apotex, 2014 FC 791 - successful challenge to the validity of a patent relating to the formulation of a glaucoma medication (travoprost), on the basis of obviousness
- Alcon Canada v. Apotex, 2014 FC 699 - successful challenge to the validity of a patent relating to a glaucoma medication (travoprost), on the bases of anticipation and obviousness
| Education | University of Pittsburgh (Ph.D., 2005) McMaster University (B.Sc. (Honours), 2000) |
